• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Spectral AI Inc.

    11/14/24 4:09:49 PM ET
    $MDAI
    Medical/Dental Instruments
    Health Care
    Get the next $MDAI alert in real time by email
    SC 13G/A 1 d796843dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G/A

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Spectral AI, Inc.

    (Name of Issuer)

    Common stock, par value $0.0001 per share

    (Title of Class of Securities)

    84757T105

    (CUSIP Number)

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 84757T105

     

     1.   

     Names of Reporting Persons.

     I.R.S. Identification Nos. of above persons (entities only).

     

     Octopus Investments Limited

     2.  

     Check the Appropriate Box if a Member of a Group (See Instructions)

     (a) ☐  (b) ☐

     

     3.  

     SEC Use Only

     

     4.  

     Citizenship or Place of Organization

     

     United Kingdom

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

       5.   

     Sole Voting Power

     

     0

       6.  

     Shared Voting Power

     

     0

       7.  

     Sole Dispositive Power

     

     0

       8.  

     Shared Dispositive Power

     

     0

     9.   

     Aggregate Amount Beneficially Owned by Each Reporting Person

     

     0

    10.  

     Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

     ☐

    11.  

     Percent of Class Represented by Amount in Row (9)

     

     0

    12.  

     Type of Reporting Person (See Instructions)

     

    HC, CO


    This Amendment No. 1 to Statement on Schedule 13G (the “Amendment”) is being filed by Octopus Investments Limited (the “Reporting Person”) that amends, supplements and supersedes the initial Statement on Schedule 13G filed by the Reporting Person with the U.S. Securities and Exchange Commission on February 8, 2024 (the “Schedule 13G”). This Amendment is the final amendment to the Schedule 13G and constitutes an exit filing for the Reporting Person. 

    Item 1.

    (a) Name of Issuer:

    Spectral AI, Inc.

    (b) Address of Issuer’s Principal Executive Offices:

    2515 McKinney Avenue

    Suite 1000

    Dallas, TX 75201

    Item 2.

    (a) Name of Person Filing:

    Octopus Investments Limited

    (b) Address of Principal Business Office or, if none, Residence:

    6th Floor, 33 Holborn, London, EC1N 2HT

    (c) Citizenship:

    United Kingdom

    (d) Title of Class of Securities:

    Common Stock, $0.0001 par value per share.

    (e) CUSIP Number:

    84757T105

     

    Item 3.

    If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

    Not applicable

     

    Item 4.

    Ownership

    (a) Amount beneficially owned:

    The information required by Item 4(a) is set forth in Row 9 of the cover page for the Reporting Person and is incorporated herein by reference.


    (b) Percent of class:

    The information required by Item 4(b) is set forth in Row 11 of the cover page for the Reporting Person and is incorporated herein by reference.

    (c) Number of shares as to which the person has:

    The information required by Item 4(c) is set forth in Rows 5-8 of the cover page for the Reporting Person and is incorporated herein by reference.

    This filing is the final amendment to the Schedule 13G and constitutes an exit filing for the Reporting Person.

     

    Item 5.

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person

    Not applicable

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

    Not Applicable

     

    Item 8.

    Identification and Classification of Members of the Group

    Not applicable

     

    Item 9.

    Notice of Dissolution of Group

    Not applicable

     

    Item 10.

    Certifications

    Not applicable


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: November 14, 2024

     

    Octopus Investments Limited
    By:  

    /s/ John Averill

      Name: John Averill
      Title: CRO
    Get the next $MDAI alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $MDAI

    DatePrice TargetRatingAnalyst
    1/23/2024$4.00Buy
    BTIG Research
    More analyst ratings

    $MDAI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BTIG Research initiated coverage on Spectral AI with a new price target

      BTIG Research initiated coverage of Spectral AI with a rating of Buy and set a new price target of $4.00

      1/23/24 7:24:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Dimaio John Michael was granted 11,700 shares, increasing direct ownership by 0.47% to 2,503,608 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      6/10/25 4:01:14 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Director Mellish Martin C.B. was granted 5,000 shares, increasing direct ownership by 26% to 24,398 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      6/6/25 4:00:24 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Director Cotton Richard John was granted 9,699 shares, increasing direct ownership by 17% to 66,927 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/1/25 4:00:30 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    SEC Filings

    See more
    • Spectral AI Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Spectral AI, Inc. (0001833498) (Filer)

      6/30/25 4:00:39 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

      8-K - Spectral AI, Inc. (0001833498) (Filer)

      6/3/25 4:01:21 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Spectral AI, Inc. (0001833498) (Filer)

      5/30/25 4:00:32 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $MDAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Spectral AI Announces Submission to FDA of its DeepView® System

      DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ:MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration ("FDA") in 2018 and uses multi-spectral imaging and artificial intelligence ("AI") algorithms to predict burn healing potential, today announced the submission of its De Novo 510k marketing clearance application to the FDA for the DeepView System, intended for use in burn care settings, including both burn centers and emergency departments. The De Novo regulatory pathway is being pursued due to the novel nature of this technology, which does not have a pred

      6/30/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape

      Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 20, 2025 /PRNewswire/ -- Equity Insider News Commentary – Amid the wave of new AI-powered innovations in healthcare, so far ambient scribes have emerged as the breakout use case. As the range of AI uses for the healthcare sector continues to grow, experts are analyzing the potential ROI on their implementation, and how much they'll benefit early adopters. Healthcare leaders are already seeing improvements, such as slashed clinician workloads from voice AI, and the adoption of AI agents to increase efficiency and smarter care delivery. For investors looking for remaining early-mover advantages, ther

      6/20/25 9:11:00 AM ET
      $CBLL
      $GEHC
      $MDAI
      $PLTR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
      Medical Electronics
      Medical/Dental Instruments
    • Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer

      DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Stanley Micek has been named the Company's Chief Operating Officer ("COO"). Micek's promotion reflects his role change from Interim COO of the Company since May, 2024 "Stan has demonstrated exceptional leadership, operational insight, and a deep understanding of our business during his time as interim COO," said Dr. J. Michael DiMaio, M.D., Chairman of the Company's Board of Directors. "His efforts leading our Research and Devel

      5/30/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Dimaio John Michael bought $10,320 worth of shares (6,000 units at $1.72), increasing direct ownership by 0.40% to 2,491,908 units (SEC Form 4)

      4 - Spectral AI, Inc. (0001833498) (Issuer)

      5/14/24 11:17:43 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Leadership Updates

    Live Leadership Updates

    See more
    • Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer

      DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Stanley Micek has been named the Company's Chief Operating Officer ("COO"). Micek's promotion reflects his role change from Interim COO of the Company since May, 2024 "Stan has demonstrated exceptional leadership, operational insight, and a deep understanding of our business during his time as interim COO," said Dr. J. Michael DiMaio, M.D., Chairman of the Company's Board of Directors. "His efforts leading our Research and Devel

      5/30/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders

      DALLAS, May 29, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, announced results from its 2025 Annual Meeting of Stockholders held earlier today. A total of 15,551,068 shares representing 60.8% of the Company's total shares outstanding were represented at the meeting, either in person or by proxy. Both of the proposals set forth by the Company were approved by its stockholders. The voting results are detailed below. Six directors were elected to serve on the Company's Board of Directors until the next Annual Me

      5/29/25 8:00:00 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Set to Join Russell Microcap® Index

      DALLAS, May 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it is set to join the Russell Microcap® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective following the closing of US equity markets on Friday, June 28, 2024 according to a preliminary list of additions posted Friday, May 24, 2024. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Tuesday, April 30, 2024 ranking them by total market capitalization. Members

      5/29/24 8:31:22 AM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Financials

    Live finance-specific insights

    See more
    • Spectral AI Announces 2025 First Quarter Financial Results

      Q1 Overview Research & Development Revenue of $6.7 MillionImproved Capital Structure Reflected in Cash of $14.1 MillionContinued work on planned De Novo submission to the FDA in the first half of 2025 DALLAS, May 13, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the first quarter ended March 31, 2025 and provided an update on its ongoing business activities. "During the first quarter we continued to execute against our strategic plan and are working hard towards our De Nov

      5/13/25 4:05:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

      DALLAS, May 02, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential today announced that it will report financial results for the first quarter ended March 31, 2025 on Tuesday, May 13, 2025 after the close of the stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 833-630-1956 - U.S.412-317-1837 - International A simultaneous webcast of the call may be accessed online from the Events

      5/2/25 4:00:00 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

      2024 Research & Development Revenue of $30 Million Successful Results from the US Burn Validation Study On Track for Regulatory Submission in US for DeepView™ System DALLAS, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence ("AI") company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the fourth quarter ("Q4 2024") and full year ("FY 2024") ended December 31, 2024, and provided an update on its ongoing business activities. "Spectral AI achieved much in 2024. Our top-l

      3/27/25 4:55:44 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care

    $MDAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Spectral AI Inc.

      SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

      11/14/24 4:09:49 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Spectral AI Inc. (Amendment)

      SC 13G/A - Spectral AI, Inc. (0001833498) (Subject)

      4/19/24 6:49:51 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Spectral AI Inc. (Amendment)

      SC 13D/A - Spectral AI, Inc. (0001833498) (Subject)

      2/27/24 2:07:28 PM ET
      $MDAI
      Medical/Dental Instruments
      Health Care